Depending on the fungus and growth conditions, the proportion and structural composition of cell wall components varies considerably ( Free, 2013, Erwig and Gow, 2016, Gow and Netea, 2016, Gow et al., 2017). The fungal cell wall is a promising antifungal target for the therapeutic treatment of human fungal pathogens because the major components - chitin, glucan, and mannan, are absent from the human body. The fungal cell wall is a dynamic organelle that is essential for its viability. These observations suggest that there are significant differences in the mode of action of PA and caspofungin and that PA or PA analogues are not likely to have broad spectrum activity in the treatment of Candida infections. parapsilosis were more sensitive to PA than C. Strains with point mutations (S645Y or S645P) in the hotspot1 region of the β-1,3-glucan synthase subunit Fks1, had decreased sensitivity to caspofungin but increased sensitivity to PA. Here, we show that PA sensitivity is regulated by the calcineurin pathway and that susceptibility to PA varied significantly between Candida species, but did not correlate with in vitro β-glucan synthase activity, cell wall β-glucan content or the sensitivity of the species to caspofungin. However, the antifungal activity of PA against human pathogenic Candida species has not been explored and the precise mode of action of this compound is not understood. As with the echinocandins, such as caspofungin, PA targets the synthesis of cell wall β-1,3-glucan and has potential utility in the treatment of medically important fungi. Recently a plant natural product poacic acid (PA) was shown to inhibit β-1,3-glucan synthesis, and to have antifungal activity against a range of plant pathogens and against Saccharomyces cerevisiae. The rise of widespread antifungal resistance fuels the need to explore new classes of inhibitory molecules as potential novel inhibitors.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |